Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis

INTRODUCTION: Immune checkpoint inhibitors (ICI) have improved outcomes for patients with many malignancies. However, these treatments are associated with immune-related adverse events, including pulmonary toxicity (pneumonitis). Pneumonitis is associated with significant short-term morbidity and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis Puente, Andrea, Johnson, Douglas B, Bastarache, Julie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083847/
http://dx.doi.org/10.1136/bmjresp-2022-001342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083847/
http://dx.doi.org/10.1136/bmjresp-2022-001342

Ejemplares similares